Edition:
United States

Urogen Pharma Ltd (URGN.OQ)

URGN.OQ on NASDAQ Stock Exchange Global Market

37.10USD
14 Dec 2017
Change (% chg)

$0.30 (+0.82%)
Prev Close
$36.80
Open
$36.85
Day's High
$37.89
Day's Low
$36.66
Volume
37,638
Avg. Vol
28,431
52-wk High
$44.38
52-wk Low
$13.01

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Arie Belldegrun

67 2012 Chairman of the Board

Ron Bentsur

51 2015 Chief Executive Officer, Director

Gary Titus

57 2015 Chief Financial Officer

Gil Hakim

47 2015 President - Israeli Operation

Chaim Hurvitz

56 2013 Director